Advertisement
Home Blog Page 2060
Children of men with testicular germ-cell cancer have a modestly increased risk for congenital malformation

Testicular Cancer Treatment Does Not Up Risk for Offspring Birth Defects

0
No increased risk seen at posttreatment in children of fathers with testicular germ-cell cancer
Fewer U.S. Army personnel have ideal cardiovascular health compared with their peers in the civilian population

Cardiovascular Health Poorer in Army Personnel Than Civilians

0
Prevalence of ideal blood pressure lower in U.S. Army personnel versus NHANES respondents
For middle-aged adults

Increase in CV Mortality Smaller With Medicaid Expansion

0
Counties in states that expanded Medicaid had significantly smaller increase in cardiovascular mortality
There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among military veterans with type 2 diabetes

No Evidence of Legacy Effect Seen for Intensive Glucose Lowering

0
Findings based on 15-year follow-up study conducted among veterans with type 2 diabetes
Fragmentation profiles of cell-free DNA can differentiate between patients with cancer and healthy controls

Fragmentation Profiles of Cell-Free DNA Can Detect Cancer

0
Combined with mutation-based cell-free DNA analyses, 91 percent of cancer patients identified
The electronic-AsthmaTracker app aids self-monitoring and improves asthma outcomes among pediatric patients and their parents

App Helps Pediatric Asthma Patients, Parents Self-Monitor

0
With one year of use, improvements seen in asthma outcomes
While oncology providers are aware of the link between obesity and cancer

Few Oncologists Refer Patients to Weight Management Programs

0
Providers need more support to refer patients to weight management, physical activity programs
The U.S. Food and Drug Administration granted Emgality (galcanezumab-gnlm) solution the first approval for treating episodic cluster headache

Emgality Receives First FDA Approval for Treating Cluster Headache

0
Patients treated with Emgality had 8.7 fewer cluster headache attacks at 3.0 weeks versus 5.2 with placebo
For men with metastatic

ASCO: Enzalutamide Beneficial in Metastatic Prostate Cancer

0
Progression-free, overall survival longer for men with metastatic, hormone-sensitive prostate cancer
Consumption of dietary supplements

Dietary Supplements May Up Risk for Severe Medical Events

0
Increased risk seen in association with supplements sold for muscle building, energy, weight loss